Sinocare Inc. (300298.SZ)

26.38 +1.80 (+7.32%) At close: 03:03PM CST

Sinocare Inc.

No. 265 Guyuan Road
Hi-tech Zone
Changsha 410205
China
86 731 8993 5770
https://www.sinocare.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 4,531

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Shao Bo Li	Chairman & GM	N/A	N/A	1965
Mr. Shi Min Wang	Deputy General Manager	N/A	N/A	1969
Mr. Jianwen Cai	Deputy General Manager	N/A	N/A	1974
Mr. Baishen Ouyang	Chairman of the Supervisory Board & Assistant to the GM	N/A	N/A	1978
Mr. Chungeng Chen	Supervisor & Supply Chain Director	N/A	N/A	1977

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Sinocare Inc. engages in the development, manufacture, and marketing of rapid diagnosis testing products primarily in the People's Republic of China. It offers SARS-CoV-2 antibody test strips; blood glucose monitors; bi-functional blood glucose monitors; point of care testing products; digital management tool solutions; non-invasive screening products; diabetes peripheral products; and PTS and Trividia Products. The company provides its products for the patients with chronic diseases and diabetes, as well as for healthcare professionals. It also exports its products to approximately 135 countries. Sinocare Inc. was founded in 2002 and is based in Changsha, the People's Republic of China.

Corporate governance

Sinocare Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.